Clinical Trials Browser

EBV-associated Tumors × Immune Checkpoint Inhibitors × Clear all

NCT07349836 2026-01-20

Application of mRNA Immunotherapy Technology in EB Virus Related Diseases

Phase EARLY_PHASE1 Not yet recruiting

EBV-associated Tumors

NCT07101536 2025-08-03

The Application of mRNA Immunotherapy Technology in Refractory Malignancies Associated With Epstein-Barr Virus (EBV)

Phase NA Not yet recruiting

EBV-associated Tumors